Results 31 to 40 of about 34,883 (151)

Apheresis in Autoimmune Encephalitis and Autoimmune Dementia [PDF]

open access: yesJournal of Clinical Medicine, 2020
Autoimmune encephalitis (AE) is a rapidly progressive inflammatory neurological disease. Underlying autoantibodies can bind to neuronal surfaces and synaptic proteins resulting in psychiatric symptoms, focal neurological signs, autonomic dysfunction and cognitive decline.
Rosa Rössling, Harald Prüss
openaire   +3 more sources

Leucine-rich glioma inactivated-1 and voltage gated potassium channel autoimmune encephalitis associated with ischemic stroke; A Case Report

open access: yesFrontiers in Neurology, 2016
Autoimmune encephalitis is associated with a wide variety of antibodies and clinical presentations. Voltage gated potassium channel (VGKC) antibodies are a cause of autoimmune non-paraneoplastic encephalitis characterized by memory impairment ...
Marisa Patryce McGinley   +2 more
doaj   +1 more source

Comparison of commercial and in-house tissue-based and cell-based assays for the detection of autoantibodies targeting neuronal surface proteins: a prospective cohort study

open access: yesFrontiers in Immunology
IntroductionThe detection of antibodies targeting neuronal antigens is a keystone for the diagnosis of autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS).
David Goncalves   +17 more
doaj   +1 more source

Pediatric autoimmune encephalitis

open access: yesJournal of Pediatric Neurosciences, 2017
Autoimmune (antibody mediated) encephalitis (AE) is emerging as a more common cause of pediatric encephalopathy than previously thought. The autoimmune process may be triggered by an infection, vaccine, or occult neoplasm. In the latter case, onconeural autoantibodies are directed against intracellular neuronal antigens, but a recent heterogeneous ...
Barbagallo M   +5 more
openaire   +3 more sources

Mimics of Autoimmune Encephalitis

open access: yesNeurology Neuroimmunology & Neuroinflammation, 2023
The clinical criteria for autoimmune encephalitis (AE) were proposed by Graus et al. in 2016. In this study, the AE criteria were validated in the real world, and common AE mimics were described. In addition, criteria for probable anti-LGI1 encephalitis were proposed and validated.In this retrospective cohort study, patients referred to our national ...
Robin W. Van Steenhoven   +15 more
openaire   +2 more sources

Recurrent Anti-AMPA Receptor Limbic Encephalitis: A Case Report and Literature Review

open access: yesFrontiers in Neurology, 2021
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a relatively rare anti-neuronal surface antigen autoimmune encephalitis (LE).
Yuanyuan Fang, Dengji Pan, Hao Huang
doaj   +1 more source

Autoimmune Encephalitis Misdiagnosis in Adults

open access: yesJAMA Neurology, 2023
ImportanceAutoimmune encephalitis misdiagnosis can lead to harm.ObjectiveTo determine the diseases misdiagnosed as autoimmune encephalitis and potential reasons for misdiagnosis.Design, Setting, and ParticipantsThis retrospective multicenter study took place from January 1, 2014, to December 31, 2020, at autoimmune encephalitis subspecialty outpatient ...
Flanagan, EP   +20 more
openaire   +2 more sources

Assessment of long-term psychosocial outcomes in N-methyl-D-aspartate receptor encephalitis – the SAPIENCE study protocol

open access: yesBMC Neurology
Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase.
Ole Jonas Boeken   +13 more
doaj   +1 more source

NMDA Autoimmune Encephalitis and Severe Persistent Hypokalemia in a Pregnant Woman

open access: yesBrain Sciences, 2022
Introduction: For more than a decade, NMDAR autoimmune encephalitis has been studied and treated as a neurological condition, and good results have been achieve through immune therapies.
Daniela Reisz   +4 more
doaj   +1 more source

Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results

open access: yesCancer Immunology, Immunotherapy
Immune checkpoint inhibitors (ICI), i.e., anti-PD1/PDL1 and anti-CTLA-4, have reshaped the prognosis of many cancers. Increased use of ICI has led to the onset of new adverse events.
Morgan Zenatri   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy